Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Raw Materials (2018 - 2019)

Niagen Bioscience (NAGE) has disclosed Raw Materials for 2 consecutive years, with $1.4 million as the latest value for Q4 2019.

  • On a quarterly basis, Raw Materials rose 81.62% to $1.4 million in Q4 2019 year-over-year; TTM through Dec 2019 was $1.4 million, a 81.62% increase, with the full-year FY2019 number at $1.4 million, up 81.62% from a year prior.
  • Raw Materials was $1.4 million for Q4 2019 at Niagen Bioscience, up from $751000.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.4 million in Q4 2019 to a low of $751000.0 in Q4 2018.